Global Dry Powder Inhaler Device Market Research Report 2023(Status and Outlook)

Global Dry Powder Inhaler Device Market Research Report 2023(Status and Outlook)



Report Overview

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, etc. are the key players in the global Dry Powder Inhaler Device market. Top 4 took up more than 30% of the global market.

From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%. In addition, Asia Pacific is also play important role in Global market.

Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%. Then followed by the COPD.

According to the Segmentation of types, all the market of Dry Powder Inhaler Device can be divided as follows: Multi-dose, Single-dose.

The Global Dry Powder Inhaler Device Market Size was estimated at USD 749.8 million in 2022 and is projected to reach USD 1048.03 million by 2029, exhibiting a CAGR of 0.05 during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Dry Powder Inhaler Device market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Dry Powder Inhaler Device Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Dry Powder Inhaler Device market in any manner.

Global Dry Powder Inhaler Device Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GlaxoSmithKline

AstraZeneca

Boehringer Ingelheim

Chiesi

Cipla

3M

Hovione

Mannkind

Mylan

Novartis

Schering/Merck

Teva

Vectura

Market Segmentation (by Type)

Single Dose

Multi Dose

Market Segmentation (by Application)

Supermarket

Convenience Store

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Dry Powder Inhaler Device Market

Overview of the regional outlook of the Dry Powder Inhaler Device Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Dry Powder Inhaler Device
1.2 Key Market Segments
1.2.1 Dry Powder Inhaler Device Segment by Type
1.2.2 Dry Powder Inhaler Device Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Dry Powder Inhaler Device Market Overview
2.1 Global Market Overview
2.1.1 Global Dry Powder Inhaler Device Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Dry Powder Inhaler Device Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Dry Powder Inhaler Device Market Competitive Landscape
3.1 Global Dry Powder Inhaler Device Sales by Manufacturers (2018-2023)
3.2 Global Dry Powder Inhaler Device Revenue Market Share by Manufacturers (2018-2023)
3.3 Dry Powder Inhaler Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Dry Powder Inhaler Device Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Dry Powder Inhaler Device Sales Sites, Area Served, Product Type
3.6 Dry Powder Inhaler Device Market Competitive Situation and Trends
3.6.1 Dry Powder Inhaler Device Market Concentration Rate
3.6.2 Global 5 and 10 Largest Dry Powder Inhaler Device Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Dry Powder Inhaler Device Industry Chain Analysis
4.1 Dry Powder Inhaler Device Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Dry Powder Inhaler Device Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Dry Powder Inhaler Device Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Dry Powder Inhaler Device Sales Market Share by Type (2018-2023)
6.3 Global Dry Powder Inhaler Device Market Size Market Share by Type (2018-2023)
6.4 Global Dry Powder Inhaler Device Price by Type (2018-2023)
7 Dry Powder Inhaler Device Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Dry Powder Inhaler Device Market Sales by Application (2018-2023)
7.3 Global Dry Powder Inhaler Device Market Size (M USD) by Application (2018-2023)
7.4 Global Dry Powder Inhaler Device Sales Growth Rate by Application (2018-2023)
8 Dry Powder Inhaler Device Market Segmentation by Region
8.1 Global Dry Powder Inhaler Device Sales by Region
8.1.1 Global Dry Powder Inhaler Device Sales by Region
8.1.2 Global Dry Powder Inhaler Device Sales Market Share by Region
8.2 North America
8.2.1 North America Dry Powder Inhaler Device Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Dry Powder Inhaler Device Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Dry Powder Inhaler Device Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Dry Powder Inhaler Device Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Dry Powder Inhaler Device Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Dry Powder Inhaler Device Basic Information
9.1.2 GlaxoSmithKline Dry Powder Inhaler Device Product Overview
9.1.3 GlaxoSmithKline Dry Powder Inhaler Device Product Market Performance
9.1.4 GlaxoSmithKline Business Overview
9.1.5 GlaxoSmithKline Dry Powder Inhaler Device SWOT Analysis
9.1.6 GlaxoSmithKline Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Dry Powder Inhaler Device Basic Information
9.2.2 AstraZeneca Dry Powder Inhaler Device Product Overview
9.2.3 AstraZeneca Dry Powder Inhaler Device Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Dry Powder Inhaler Device SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Dry Powder Inhaler Device Basic Information
9.3.2 Boehringer Ingelheim Dry Powder Inhaler Device Product Overview
9.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Product Market Performance
9.3.4 Boehringer Ingelheim Business Overview
9.3.5 Boehringer Ingelheim Dry Powder Inhaler Device SWOT Analysis
9.3.6 Boehringer Ingelheim Recent Developments
9.4 Chiesi
9.4.1 Chiesi Dry Powder Inhaler Device Basic Information
9.4.2 Chiesi Dry Powder Inhaler Device Product Overview
9.4.3 Chiesi Dry Powder Inhaler Device Product Market Performance
9.4.4 Chiesi Business Overview
9.4.5 Chiesi Dry Powder Inhaler Device SWOT Analysis
9.4.6 Chiesi Recent Developments
9.5 Cipla
9.5.1 Cipla Dry Powder Inhaler Device Basic Information
9.5.2 Cipla Dry Powder Inhaler Device Product Overview
9.5.3 Cipla Dry Powder Inhaler Device Product Market Performance
9.5.4 Cipla Business Overview
9.5.5 Cipla Dry Powder Inhaler Device SWOT Analysis
9.5.6 Cipla Recent Developments
9.6 3M
9.6.1 3M Dry Powder Inhaler Device Basic Information
9.6.2 3M Dry Powder Inhaler Device Product Overview
9.6.3 3M Dry Powder Inhaler Device Product Market Performance
9.6.4 3M Business Overview
9.6.5 3M Recent Developments
9.7 Hovione
9.7.1 Hovione Dry Powder Inhaler Device Basic Information
9.7.2 Hovione Dry Powder Inhaler Device Product Overview
9.7.3 Hovione Dry Powder Inhaler Device Product Market Performance
9.7.4 Hovione Business Overview
9.7.5 Hovione Recent Developments
9.8 Mannkind
9.8.1 Mannkind Dry Powder Inhaler Device Basic Information
9.8.2 Mannkind Dry Powder Inhaler Device Product Overview
9.8.3 Mannkind Dry Powder Inhaler Device Product Market Performance
9.8.4 Mannkind Business Overview
9.8.5 Mannkind Recent Developments
9.9 Mylan
9.9.1 Mylan Dry Powder Inhaler Device Basic Information
9.9.2 Mylan Dry Powder Inhaler Device Product Overview
9.9.3 Mylan Dry Powder Inhaler Device Product Market Performance
9.9.4 Mylan Business Overview
9.9.5 Mylan Recent Developments
9.10 Novartis
9.10.1 Novartis Dry Powder Inhaler Device Basic Information
9.10.2 Novartis Dry Powder Inhaler Device Product Overview
9.10.3 Novartis Dry Powder Inhaler Device Product Market Performance
9.10.4 Novartis Business Overview
9.10.5 Novartis Recent Developments
9.11 Schering/Merck
9.11.1 Schering/Merck Dry Powder Inhaler Device Basic Information
9.11.2 Schering/Merck Dry Powder Inhaler Device Product Overview
9.11.3 Schering/Merck Dry Powder Inhaler Device Product Market Performance
9.11.4 Schering/Merck Business Overview
9.11.5 Schering/Merck Recent Developments
9.12 Teva
9.12.1 Teva Dry Powder Inhaler Device Basic Information
9.12.2 Teva Dry Powder Inhaler Device Product Overview
9.12.3 Teva Dry Powder Inhaler Device Product Market Performance
9.12.4 Teva Business Overview
9.12.5 Teva Recent Developments
9.13 Vectura
9.13.1 Vectura Dry Powder Inhaler Device Basic Information
9.13.2 Vectura Dry Powder Inhaler Device Product Overview
9.13.3 Vectura Dry Powder Inhaler Device Product Market Performance
9.13.4 Vectura Business Overview
9.13.5 Vectura Recent Developments
10 Dry Powder Inhaler Device Market Forecast by Region
10.1 Global Dry Powder Inhaler Device Market Size Forecast
10.2 Global Dry Powder Inhaler Device Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Dry Powder Inhaler Device Market Size Forecast by Country
10.2.3 Asia Pacific Dry Powder Inhaler Device Market Size Forecast by Region
10.2.4 South America Dry Powder Inhaler Device Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Dry Powder Inhaler Device by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Dry Powder Inhaler Device Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Dry Powder Inhaler Device by Type (2024-2029)
11.1.2 Global Dry Powder Inhaler Device Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Dry Powder Inhaler Device by Type (2024-2029)
11.2 Global Dry Powder Inhaler Device Market Forecast by Application (2024-2029)
11.2.1 Global Dry Powder Inhaler Device Sales (K Units) Forecast by Application
11.2.2 Global Dry Powder Inhaler Device Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings